Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 10233 | 48.48 |
09:34 ET | 35900 | 48.66 |
09:36 ET | 3000 | 48.745 |
09:38 ET | 1280 | 48.765 |
09:39 ET | 100 | 48.94 |
09:41 ET | 742 | 48.55 |
09:43 ET | 109793 | 48.68 |
09:48 ET | 800 | 48.78 |
09:50 ET | 1076 | 48.725 |
09:52 ET | 1524 | 48.58 |
09:54 ET | 1000 | 48.21 |
09:56 ET | 16000 | 48.29 |
09:57 ET | 2700 | 48.14 |
09:59 ET | 1100 | 48.05 |
10:01 ET | 1217 | 47.96 |
10:03 ET | 1314 | 47.95 |
10:06 ET | 2906 | 48.29 |
10:08 ET | 1643 | 48.39 |
10:10 ET | 100 | 48.355 |
10:12 ET | 600 | 48.32 |
10:14 ET | 200 | 48.32 |
10:15 ET | 723 | 48.27 |
10:17 ET | 400 | 48.28 |
10:19 ET | 400 | 48.3609 |
10:21 ET | 1455 | 48.485 |
10:24 ET | 400 | 48.55 |
10:26 ET | 1400 | 48.47 |
10:28 ET | 100 | 48.5 |
10:30 ET | 800 | 48.46 |
10:32 ET | 868 | 48.36 |
10:33 ET | 1400 | 48.5 |
10:35 ET | 200 | 48.53 |
10:37 ET | 1094 | 48.45 |
10:39 ET | 600 | 48.55 |
10:42 ET | 1200 | 48.42 |
10:44 ET | 700 | 48.25 |
10:46 ET | 300 | 48.11 |
10:48 ET | 800 | 48.12 |
10:51 ET | 300 | 48.02 |
10:53 ET | 1200 | 47.92 |
10:55 ET | 1233 | 47.99 |
10:57 ET | 800 | 47.955 |
11:00 ET | 200 | 47.975 |
11:02 ET | 400 | 48.04 |
11:04 ET | 100 | 48.06 |
11:06 ET | 2210 | 48.31 |
11:08 ET | 275 | 48.32 |
11:09 ET | 1100 | 48.29 |
11:11 ET | 20036 | 48.22 |
11:13 ET | 1808 | 48.14 |
11:15 ET | 600 | 47.94 |
11:18 ET | 400 | 48.015 |
11:20 ET | 200 | 47.95 |
11:22 ET | 1400 | 47.82 |
11:24 ET | 902 | 47.75 |
11:26 ET | 1172 | 47.89 |
11:27 ET | 400 | 47.78 |
11:29 ET | 1406 | 47.83 |
11:31 ET | 1000 | 47.74 |
11:33 ET | 200 | 47.75 |
11:36 ET | 200 | 47.8 |
11:38 ET | 29785 | 47.975 |
11:40 ET | 200 | 48.02 |
11:42 ET | 1000 | 47.85 |
11:44 ET | 700 | 47.75 |
11:45 ET | 200 | 47.75 |
11:47 ET | 200 | 47.71 |
11:49 ET | 800 | 47.735 |
11:51 ET | 1992 | 47.76 |
11:54 ET | 700 | 47.83 |
11:56 ET | 300 | 47.92 |
11:58 ET | 600 | 47.97 |
12:00 ET | 940 | 47.92 |
12:03 ET | 1019 | 47.945 |
12:07 ET | 600 | 47.925 |
12:09 ET | 2100 | 48.04 |
12:12 ET | 1100 | 47.92 |
12:18 ET | 700 | 48 |
12:20 ET | 200 | 47.98 |
12:23 ET | 200 | 47.94 |
12:25 ET | 900 | 47.94 |
12:27 ET | 1900 | 48 |
12:30 ET | 300 | 47.975 |
12:32 ET | 300 | 47.975 |
12:36 ET | 2257 | 48.005 |
12:38 ET | 200 | 47.96 |
12:39 ET | 1100 | 47.91 |
12:41 ET | 300 | 47.96 |
12:43 ET | 400 | 47.9201 |
12:45 ET | 200 | 47.95 |
12:48 ET | 500 | 47.98 |
12:50 ET | 200 | 47.96 |
12:52 ET | 200 | 47.98 |
12:54 ET | 700 | 47.97 |
12:56 ET | 500 | 47.96 |
12:57 ET | 500 | 47.98 |
12:59 ET | 2282 | 47.91 |
01:01 ET | 1000 | 47.82 |
01:03 ET | 500 | 47.77 |
01:06 ET | 400 | 47.785 |
01:08 ET | 700 | 47.78 |
01:10 ET | 1900 | 47.82 |
01:12 ET | 100 | 47.735 |
01:14 ET | 700 | 47.81 |
01:15 ET | 100 | 47.77 |
01:17 ET | 200 | 47.81 |
01:19 ET | 1104 | 47.8 |
01:21 ET | 500 | 47.745 |
01:24 ET | 500 | 47.67 |
01:26 ET | 100 | 47.71 |
01:28 ET | 1176 | 47.7075 |
01:30 ET | 100 | 47.71 |
01:32 ET | 1200 | 47.71 |
01:33 ET | 3758 | 47.47 |
01:35 ET | 200 | 47.48 |
01:37 ET | 5625 | 47.41 |
01:39 ET | 700 | 47.41 |
01:42 ET | 5505 | 47.3 |
01:44 ET | 1000 | 47.29 |
01:46 ET | 2989 | 47.23 |
01:48 ET | 748 | 47.17 |
01:50 ET | 1316 | 47.16 |
01:51 ET | 100 | 47.14 |
01:53 ET | 1996 | 47.22 |
01:55 ET | 500 | 47.25 |
01:57 ET | 300 | 47.2 |
02:00 ET | 1200 | 47.18 |
02:02 ET | 2165 | 46.96 |
02:04 ET | 970 | 46.92 |
02:06 ET | 2988 | 47.155 |
02:08 ET | 3965 | 47.15 |
02:09 ET | 10052 | 47.19 |
02:11 ET | 6234 | 47.25 |
02:13 ET | 41591 | 47.55 |
02:15 ET | 2365 | 47.7 |
02:18 ET | 600 | 47.6 |
02:20 ET | 2300 | 47.615 |
02:22 ET | 650 | 47.58 |
02:24 ET | 400 | 47.53 |
02:26 ET | 100 | 47.53 |
02:27 ET | 1000 | 47.55 |
02:29 ET | 795 | 47.55 |
02:31 ET | 1200 | 47.44 |
02:33 ET | 1300 | 47.58 |
02:36 ET | 100 | 47.62 |
02:38 ET | 300 | 47.7 |
02:40 ET | 1828 | 47.67 |
02:42 ET | 400 | 47.63 |
02:44 ET | 300 | 47.665 |
02:45 ET | 3616 | 47.81 |
02:47 ET | 700 | 47.94 |
02:49 ET | 200 | 47.95 |
02:51 ET | 1986 | 47.91 |
02:54 ET | 200 | 47.905 |
02:56 ET | 1100 | 47.85 |
02:58 ET | 5870 | 47.58 |
03:00 ET | 2200 | 47.43 |
03:02 ET | 11737 | 47.31 |
03:03 ET | 6773 | 47.67 |
03:05 ET | 1903 | 47.63 |
03:07 ET | 403 | 47.61 |
03:09 ET | 1254 | 47.61 |
03:12 ET | 1275 | 47.72 |
03:14 ET | 2103 | 47.565 |
03:16 ET | 700 | 47.62 |
03:18 ET | 600 | 47.6 |
03:20 ET | 2348 | 47.605 |
03:21 ET | 900 | 47.57 |
03:23 ET | 750 | 47.67 |
03:25 ET | 4247 | 47.68 |
03:27 ET | 3613 | 47.58 |
03:30 ET | 1362 | 47.545 |
03:32 ET | 1700 | 47.45 |
03:34 ET | 2500 | 47.59 |
03:36 ET | 1039 | 47.6 |
03:38 ET | 1109 | 47.64 |
03:39 ET | 2000 | 47.635 |
03:41 ET | 5044 | 47.8 |
03:43 ET | 700 | 47.85 |
03:45 ET | 4847 | 47.92 |
03:48 ET | 3639 | 48.075 |
03:50 ET | 4995 | 47.95 |
03:52 ET | 9782 | 47.85 |
03:54 ET | 4475 | 47.96 |
03:56 ET | 13919 | 47.755 |
03:57 ET | 17050 | 47.93 |
03:59 ET | 40491 | 47.93 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.8B | -12.7x | --- |
Nuvalent Inc | 4.2B | -27.4x | --- |
Immunovant Inc | 4.3B | -16.4x | --- |
Summit Therapeutics Inc | 3.3B | -3.1x | --- |
Madrigal Pharmaceuticals Inc | 4.4B | -9.2x | --- |
Biohaven Ltd | 3.1B | -6.0x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.8B |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.7x |
Price/Sales (TTM) | 1,914.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.